The Nigerian Senate has initiated discussions on a significant bill aimed at modernizing regulations surrounding emerging health technologies, including AI-assisted diagnostics and other biotech innovations.
This proposed legislation seeks to replace outdated laws governing food and medical products with a comprehensive framework that aligns with current global standards. Senator Suleiman Sadiq emphasized the need for this update, noting that existing regulations do not adequately address advancements in healthcare and the complexities of modern pharmaceutical manufacturing.
Key features of the bill include a broadened regulatory scope under the National Agency for Food and Drug Administration and Control (NAFDAC), which will now oversee a wider range of products including advanced medical technologies and processed animal feeds. Additionally, the legislation introduces a structured approach to clinical trials and ongoing safety monitoring, enhancing product lifecycle management.
Moreover, the bill aims to improve enforcement mechanisms and supply chain traceability while incorporating internationally recognized practices such as Good Manufacturing Practices (GMP). These reforms are designed to elevate Nigeria’s healthcare sector, enhance consumer safety, and ensure that local products meet global competitiveness standards.
As the bill progresses to the Senate Committee on Health for further examination, its successful implementation could significantly transform Nigeria's approach to health technology regulation, fostering innovation while safeguarding public health.